This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window

American Economic Review: Vol. 101 No. 3 (May 2011)
AER Volume. 101, Issue 3 |
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter
AER Forthcoming Articles
Full-text Article
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter
Explore:
AER Forthcoming Articles
Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment
Article Citation
Zhang, Yuting,
Joseph P. Newhouse, and
Katherine Baicker. 2011. "Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment."
American Economic Review,
101(3): 393-97.
DOI: 10.1257/aer.101.3.393
DOI: 10.1257/aer.101.3.393
Abstract
Little is known about the relationship between variation in drug and non-drug medical treatment and how areas may substitute one type of care for the other. Using pharmacy and medical claims data for Medicare beneficiaries, we examine whether areas with more drug use have lower non-drug medical costs and how the quality of prescribing and primary care are associated with medical costs. We find that areas with higher drug spending do not have lower non-drug medical spending; however, poorer-quality prescribing and primary care are associated with higher medical spending in general and inpatient spending in particular.
Article Full-Text Access
Full-text Article
Authors
Zhang, Yuting (U Pittsburgh)
Newhouse, Joseph P. (Harvard U)
Baicker, Katherine (Harvard U)
Newhouse, Joseph P. (Harvard U)
Baicker, Katherine (Harvard U)
JEL Classifications
D12: Consumer Economics: Empirical Analysis
I11: Analysis of Health Care Markets
I18: Health: Government Policy; Regulation; Public Health
I11: Analysis of Health Care Markets
I18: Health: Government Policy; Regulation; Public Health

